发明名称
摘要 <P>PROBLEM TO BE SOLVED: To provide an antibody improved in an effector function, a method for simply producing the antibody, a method for improving the effector function of an antibody, and a therapeutic composition which contains the antibody, has a high pharmacological activity, can reduce dosages with less side effects, and can be used for wide-ranging uses. <P>SOLUTION: This antibody whose 295-amino acid in the EU index number of Kabat is replaced with a cysteine residue comprises (1) a mutein antibody whose amino acids at specific positions are replaced by other amino acids, and/or (2) an antibody in which the fucose molecules of sugar chains bound to the antibody are reduced. <P>COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP5427348(B2) 申请公布日期 2014.02.26
申请号 JP20070267207 申请日期 2007.10.12
申请人 发明人
分类号 C12N15/09;A61K39/395;A61P1/04;A61P19/02;A61P29/00;A61P35/00;A61P35/04;A61P37/06;C07K16/18;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12P21/08 主分类号 C12N15/09
代理机构 代理人
主权项
地址